As of 2024-12-15, the Relative Valuation of Sarepta Therapeutics Inc (SRPT) is 34.31 USD. This relative valuation is based on P/E multiples. With the latest stock price at 123.71 USD, the upside of Sarepta Therapeutics Inc based on Relative Valuation is -72.3%.
The range of the Relative Valuation is 24.06 - 54.90 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.1x - 43.0x | 34.4x |
| Forward P/E multiples | 18.9x - 32.8x | 19.4x |
| Fair Price | 24.06 - 54.90 | 34.31 |
| Upside | -80.6% - -55.6% | -72.3% |
| Date | P/E |
| 2024-12-13 | 96.98 |
| 2024-12-12 | 97.58 |
| 2024-12-11 | 98.30 |
| 2024-12-10 | 99.33 |
| 2024-12-09 | 101.13 |
| 2024-12-06 | 100.48 |
| 2024-12-05 | 99.00 |
| 2024-12-04 | 99.19 |
| 2024-12-03 | 98.79 |
| 2024-12-02 | 100.31 |
| 2024-11-29 | 104.53 |
| 2024-11-27 | 108.14 |
| 2024-11-26 | 102.31 |
| 2024-11-25 | 89.88 |
| 2024-11-22 | 89.55 |
| 2024-11-21 | 86.63 |
| 2024-11-20 | 86.91 |
| 2024-11-19 | 83.58 |
| 2024-11-18 | 82.06 |
| 2024-11-15 | 81.95 |
| 2024-11-14 | 85.54 |
| 2024-11-13 | 88.18 |
| 2024-11-12 | 89.62 |
| 2024-11-11 | 92.38 |
| 2024-11-08 | 95.34 |
| 2024-11-07 | 94.40 |
| 2024-11-06 | 100.32 |
| 2024-11-05 | 98.00 |
| 2024-11-04 | 96.48 |
| 2024-11-01 | 96.65 |
| 2024-10-31 | 98.78 |
| 2024-10-30 | 100.17 |
| 2024-10-29 | 102.08 |
| 2024-10-28 | 102.12 |
| 2024-10-25 | 102.81 |
| 2024-10-24 | 103.50 |
| 2024-10-23 | 101.82 |
| 2024-10-22 | 100.67 |
| 2024-10-21 | 99.80 |
| 2024-10-18 | 99.62 |
| 2024-10-17 | 97.41 |
| 2024-10-16 | 98.71 |
| 2024-10-15 | 97.00 |
| 2024-10-14 | 97.50 |
| 2024-10-11 | 97.61 |
| 2024-10-10 | 95.96 |
| 2024-10-09 | 92.50 |
| 2024-10-08 | 93.85 |
| 2024-10-07 | 92.34 |
| 2024-10-04 | 94.39 |